
MATERNUS-Kliniken-AG
XETRA:MAK

Intrinsic Value
The intrinsic value of one
MAK
stock under the Base Case scenario is
10.48
EUR.
Compared to the current market price of 1.23 EUR,
MATERNUS-Kliniken-AG
is
Undervalued by 88%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
MATERNUS-Kliniken-AG
Fundamental Analysis


Revenue & Expenses Breakdown
MATERNUS-Kliniken-AG
Balance Sheet Decomposition
MATERNUS-Kliniken-AG
Current Assets | 22.3m |
Cash & Short-Term Investments | 9.6m |
Receivables | 11.7m |
Other Current Assets | 995k |
Non-Current Assets | 128.3m |
Long-Term Investments | 979k |
PP&E | 114.1m |
Intangibles | 13.2m |
Other Non-Current Assets | -1k |
Free Cash Flow Analysis
MATERNUS-Kliniken-AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
MATERNUS-Kliniken-AG
Revenue
|
159.4m
EUR
|
Cost of Revenue
|
-21.7m
EUR
|
Gross Profit
|
137.8m
EUR
|
Operating Expenses
|
-140.9m
EUR
|
Operating Income
|
-3.1m
EUR
|
Other Expenses
|
-13m
EUR
|
Net Income
|
-16.1m
EUR
|
MAK Profitability Score
Profitability Due Diligence
MATERNUS-Kliniken-AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Score
MATERNUS-Kliniken-AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
MAK Solvency Score
Solvency Due Diligence
MATERNUS-Kliniken-AG's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Score
MATERNUS-Kliniken-AG's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MAK Price Targets Summary
MATERNUS-Kliniken-AG
Dividends
Current shareholder yield for MAK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MAK
stock under the Base Case scenario is
10.48
EUR.
Compared to the current market price of 1.23 EUR,
MATERNUS-Kliniken-AG
is
Undervalued by 88%.